Noel Donnelly
Director of Finance/CFO at PEPGEN INC.
Net worth: - $ as of 2024-05-30
Noel Donnelly active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PEPGEN INC. | Director of Finance/CFO | 2021-09-30 | - |
Career history of Noel Donnelly
Former positions of Noel Donnelly
| Companies | Position | Start | End |
|---|---|---|---|
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Director of Finance/CFO | 2019-06-30 | 2021-09-30 |
Training of Noel Donnelly
| Babson College | Masters Business Admin |
| University of Massachusetts Lowell | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Director of Finance/CFO | 2 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PEPGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Noel Donnelly
- Experience
